Trade XNCR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Xencor, Inc. (XNCR) is trading at US$26.61, down 0.04% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$2.07B. Over the past 52 weeks, XNCR has traded between US$8.19 and US$30.61. On Syfe you can trade XNCR with $0 commission and add it to your watchlist.
| Previous close | US$26.62 |
|---|---|
| Market cap | US$2.07B |
| 52-week range | US$8.19 – US$30.61 |
| Volume | 919.29K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Xencor, Inc.
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.
Year: 2013
Wedbush Adjusts Price Target on Xencor to $30 From $26, Maintains Outperform Rating
Aug 6, 12:47 PM · MT Newswires
RBC Capital Adjusts PT on Xencor to $20 From $19, Maintains Outperform Speculative Risk Rating
Aug 6, 12:01 PM · MT Newswires
-- Earnings Flash (XNCR) Xencor, Inc. Reports Q2 Revenue $51.2M, vs. FactSet Est of $18.9M
Aug 5, 8:01 PM · MT Newswires
Sector Update: Healthcare Stocks Decline Late Afternoon
Jul 30, 7:46 PM · MT Newswires
Sector Update: Healthcare
Jul 30, 7:28 PM · MT Newswires
Xencor, Inc. (XNCR) stock is trading at US$26.61, -0.04% from the previous close of US$26.62.
The market cap for Xencor, Inc. (XNCR) stock is approximately US$2.07B.
The 52-week high for Xencor, Inc. (XNCR) stock is US$30.61.
The 52-week low for Xencor, Inc. (XNCR) stock is US$8.19.
Xencor, Inc. (XNCR) does not currently pay a dividend.
Stay on top of XNCR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
